Is Cryotherapy a Cool Trend After All?
Whole-body cryotherapy may not be so cool after all, according to the US Food and Drug Administration (FDA).
What Vitamin D Might Do for MS Patients
A daily dose of vitamin D may do the body good, and that may be especially true for patients with multiple sclerosis (MS).
Rare Brain Infections Tied to MS Rx
FDA is warning that a case of definite progressive multifocal leukoencephalopathy (PML) and a case of probable PML have been reported in patients taking Gilenya (fingolimod) for multiple sclerosis (MS).
How Your Pet Can Affect Your Health
Dogs and cats can make great companions, and having a pet might be more beneficial to your health than you think. Although there is little evidence to suggest most of the health benefits, here’s a list of ways that pets might be able to benefit your health.
FDA Investigating Rare Brain Infection in Patient Taking Gilenya (fingolimod)
The US Food and Drug Administration (FDA) is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis (MS) has developed a rare and serious brain infection after taking the drug Gilenya (fingolimod).
Cardiovascular Monitoring With Gilenya
The U.S. Food and Drug Administration (FDA) has completed its evaluation of a report of a patient who died after the first dose of multiple sclerosis drug Gilenya ( fingolimod ).
Potential Dangers of Multiple Sclerosis Treatment
The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation therapy” or the “liberation procedure” to treat chronic cerebrospinal venous insufficiency ( CCSVI ).
A Wheelchair that Sees
Researchers from Florida State University and the University of Pittsburg are developing a new tool that will help those in electric wheelchairs safely navigate difficult terrain.